X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ppv23 (15) 15
index medicus (12) 12
pneumonia (9) 9
vaccination (9) 9
vaccines (9) 9
conjugate vaccine (8) 8
humans (8) 8
immunology (8) 8
adults (7) 7
immunization (7) 7
polysaccharides (7) 7
disease (6) 6
pcv13 (6) 6
polysaccharide vaccine (6) 6
age (5) 5
female (5) 5
male (5) 5
medicine, research & experimental (5) 5
pneumococcal infections - prevention & control (5) 5
streptococcus pneumoniae (5) 5
23-valent pneumococcal polysaccharide vaccine (4) 4
aged (4) 4
children (4) 4
immunogenicity (4) 4
impact (4) 4
pneumococcal (4) 4
streptococcus infections (4) 4
adult (3) 3
bacterial pneumonia (3) 3
elderly (3) 3
epidemiology (3) 3
infectious diseases (3) 3
internal medicine (3) 3
markov chains (3) 3
middle aged (3) 3
older (3) 3
older people (3) 3
pneumococcal infections - epidemiology (3) 3
pneumococcal pneumonia (3) 3
pneumococcal vaccines - administration & dosage (3) 3
pneumococcal vaccines - economics (3) 3
quality-adjusted life years (3) 3
risk factors (3) 3
risk groups (3) 3
streptococcus-pneumoniae (3) 3
adolescent (2) 2
adult vaccination (2) 2
aged, 80 and over (2) 2
antibodies, bacterial - blood (2) 2
antibody-response (2) 2
asthma (2) 2
biotechnology & applied microbiology (2) 2
child (2) 2
community-acquired pneumonia (2) 2
confidence intervals (2) 2
conjugates (2) 2
cost analysis (2) 2
cost-benefit analysis (2) 2
cost-effectiveness (2) 2
economic evaluation (2) 2
efficacy (2) 2
fatalities (2) 2
health care (2) 2
health care sciences & services (2) 2
hiv infection (2) 2
hospitals (2) 2
immune response (2) 2
immunoglobulin g (2) 2
invasive pneumococcal disease (2) 2
laboratories (2) 2
medical care, cost of (2) 2
medical research (2) 2
medicine (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
morbidity (2) 2
patients (2) 2
pneumococcal polysaccharide vaccine (2) 2
pneumococcal vaccination (2) 2
pneumococcal vaccines - immunology (2) 2
practice guidelines as topic (2) 2
prevention (2) 2
research (2) 2
research paper (2) 2
risk (2) 2
safety (2) 2
sensitivity analysis (2) 2
serologic response (2) 2
serotypes (2) 2
13-valent pneumococcal conjugate vaccine (1) 1
1506 (1) 1
1698 (1) 1
1706 (1) 1
1723 (1) 1
1731 (1) 1
abridged index medicus (1) 1
acip, advisory committee on immunization practices (1) 1
activation (1) 1
active antiretroviral therapy (1) 1
adult thoracic medicine (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pulmonologiya, ISSN 0869-0189, 2016, Volume 26, Issue 1, pp. 29 - 37
Journal Article
Clinical Immunology, ISSN 1521-6616, 08/2018, Volume 193, pp. 1 - 9
The PPV23 immunizes healthy elderly and other high-risk populations against pneumococcal disease. Immune mechanisms whereby these populations differently mount... 
OPA | PPV23 | TB-cured elderly | HIV infection | MYCOBACTERIUM-TUBERCULOSIS | CONTROLLED-TRIAL | CONJUGATE VACCINE | IMMUNOLOGY | HIV-INFECTED ADULTS | CHILDREN | MEMORY B-CELLS | STREPTOCOCCUS-PNEUMONIAE | REINFECTION | DISEASE | DOUBLE-BLIND
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 4/2019, Volume 38, Issue 4, pp. 785 - 791
Journal Article
Vaccine, ISSN 0264-410X, 10/2018, Volume 36, Issue 42, pp. 6307 - 6313
Journal Article
Annals of the American Thoracic Society, ISSN 2325-6621, 07/2014, Volume 11, Issue 6, pp. 969 - 974
Streptococcus pneumoniae infection is a common and serious health problem that is best prevented by the pneumococcal vaccine. The first vaccine approved by the... 
PCV13 | Adults | PPV23 | Pneumococcal vaccine | Vaccination | adults | pneumococcal vaccine | vaccination | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - pharmacology | United States | Centers for Disease Control and Prevention (U.S.) | Humans | Practice Guidelines as Topic
Journal Article
Journal of Clinical Epidemiology, ISSN 0895-4356, 2013, Volume 66, Issue 1, pp. 36 - 43
Abstract Objective To study the seroepidemiology and antimicrobial resistance pattern of invasive pneumococcal disease (IPD) in older subjects who are admitted... 
Internal Medicine | Surveillance | STG | Invasive pneumococcal disease | Antimicrobial resistance | Serotype group | PPV23 | S pneumoniae | 23-valent pneumococcal polysaccharide vaccine | UNITED-STATES | OLDER-ADULTS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | STREPTOCOCCUS-PNEUMONIAE | COMMUNITY | HEALTH CARE SCIENCES & SERVICES | POLYSACCHARIDE VACCINE | Pneumococcal Infections - drug therapy | Meningitis, Pneumococcal - microbiology | Streptococcus pneumoniae - drug effects | Pneumonia, Pneumococcal - microbiology | Prospective Studies | Humans | Middle Aged | India - epidemiology | Pneumococcal Infections - mortality | Male | Meningitis, Pneumococcal - mortality | Meningitis, Pneumococcal - drug therapy | Pneumonia, Pneumococcal - mortality | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Pneumococcal Infections - epidemiology | Pneumonia, Pneumococcal - epidemiology | Drug Resistance, Multiple, Bacterial | Female | Meningitis, Pneumococcal - epidemiology | Pneumococcal Infections - microbiology | Pneumonia, Pneumococcal - drug therapy | Drug resistance | Epidemiology | Pneumonia | Immunization | Bacterial infections | Disease | Laboratories | Mortality | Antimicrobial agents | Hospitalization | Vaccines | Streptococcus infections | Confidence intervals | Hospitals | Sheep | Nosocomial infections | Methods
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 12/2014, Volume 10, Issue 12, pp. 3700 - 3710
HIV-infected patients remain at higher risk for pneumococcal disease than the general population despite immune reconstitution and suppression of HIV... 
OPA, opsonophagocytic activity | PPV, pneumococcal polysaccharide vaccine | PPV23, 23-valent pneumococcal polysaccharide vaccine | pneumococcal disease | invasive pneumococcal disease | ELISA, enzyme-linked immunosorbent assay | GMT, geometric mean titer | EACS, European AIDS Clinical Society | cART, combination antiretroviral therapy | immunodeficiency | IPD, invasive pneumococcal disease | ART, antiretroviral therapy | pneumococcal conjugate vaccine | TLR, toll-like receptor | PCV13, 13-valent pneumococcal conjugate vaccine | PCV7, 7-valent pneumococcal conjugate vccine | ACIP, Advisory Committee on Immunization Practices | AIDS | NA, not available | PVL, plasma HIV RNA load | immunogenicity | Streptococcus pneumoniae | DHHS, Department of Health and Human Services | pneumococcal polysaccharide vaccine | PCV, pneumococcal conjugate vaccine | Pneumococcal conjugate vaccine | Immunogenicity | Pneumococcal polysaccharide vaccine | Immunodeficiency | Invasive pneumococcal disease | Pneumococcal disease | RISK-FACTORS | CONJUGATE VACCINE | FOLLOW-UP | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | B-CELLS | CHANGING EPIDEMIOLOGY | DRUG-USERS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SEROLOGIC RESPONSE | POLYSACCHARIDE VACCINE | ANTIBODY-RESPONSE | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Vaccines, Conjugate - immunology | Virus Replication | Humans | Vaccination | Pneumococcal Vaccines - immunology | Adult | HIV Infections - drug therapy | CD4 Lymphocyte Count | Drug Therapy, Combination | Practice Guidelines as Topic
Journal Article
Postgraduate Medicine, ISSN 0032-5481, 09/2010, Volume 122, Issue 5, pp. 116 - 124
Journal Article